Clinical reference Biomarker Directory
Back to directory

Hexokinase

Emerging

Hexokinase deficiency is an extremely rare glycolytic enzyme cause of hereditary hemolytic anemia.

Also known as HK hexokinase 1
In plain language

Hexokinase is the very first step in how cells process glucose for energy. An extremely rare inherited shortage of it causes anemia, similar to but even rarer than the other red-cell enzyme deficiencies discussed in this set.

Biomarker & context

Hexokinase is the first enzyme in the glycolysis pathway, catalyzing the initial step of glucose metabolism in red blood cells and other tissues.

What it indicates

Hereditary hexokinase deficiency is an extremely rare cause of non-spherocytic hemolytic anemia, following the same general enzyme-deficiency hemolytic anemia pattern discussed for pyruvate kinase, GPI, and other glycolytic enzymes in this biomarker set.

Diagnosis & clinical testing

Diagnosed via red blood cell enzyme activity assay after excluding more common causes; this is among the rarest of the glycolytic enzyme deficiencies, with only a small number of cases reported in medical literature.

Guiding treatment

Management is supportive, similar to the other red cell enzyme deficiencies discussed in this biomarker set, given the absence of any enzyme-specific treatment.

Clinical significance

Among the rarest of the glycolytic enzyme deficiencies, with very few cases reported in medical literature.

References
  1. General hematology reference literature on rare glycolytic enzyme deficiencies causing hereditary hemolytic anemia.